CE Research/Coverage Link Not Addressed In House Health Reform Draft
The draft health reform legislation unveiled jointly by three House committees June 19 does not specifically address the use of comparative effectiveness research in treatment or coverage decisions, which should raise a red flag for the pharmaceutical industry
You may also be interested in...
Senate HELP hearing, Senate Finance delay reveal opposition talking points are turning into practice as health reform efforts hit critical phase.
Finance Committee CER proposal has been in works for over a year and has generally been viewed by industry as best way to approach CER in health care reform.
The Senate Health, Education, Labor and Pensions Committee's health care reform bill is headed to markup beginning June 16, although details of key provisions, including establishment of a public insurance option, are still being developed